Why the study?
Ketones are alternative energy substrates for the heart and kidney, but no studies had investigated their metabolism simultaneously in both organs in humans.
Does the ketone radiotracer 11C-acetoacetate have different organ distribution and basal kinetic rates compared to 11C-acetate in the heart and kidneys of healthy humans?
Cross-Sectional (n=10)
Randomized order of tracers
No
Does the ketone radiotracer 11C-acetoacetate have different organ distribution and basal kinetic rates compared to 11C-acetate in the heart and kidneys of healthy humans?
This dual-tracer PET study demonstrates that 11C-acetoacetate and 11C-acetate have similar kinetics in the heart but distinct absorption and metabolism profiles in the kidney, establishing a method to study cardiorenal ketone metabolism.
Answers are grounded in this paper and cite their sources.
May support dual-organ ketone imaging research; leaves open clinical relevance in cardiorenal disease.
Ketones are alternative energy substrates for the heart and kidney but no studies have investigated their metabolism simultaneously in both organs in humans. The present double tracer positron emission tomography (PET) study evaluated the organ distribution and basal kinetic rates of the radiolabeled ketone, 11 C-acetoacetate ( 11 C-AcAc), in the heart and kidney compared to 11 C-acetate ( 11 C-Ac), which is a well-validated metabolic radiotracer. Both tracers were highly metabolized by the left ventricle and the renal cortex. In the heart, kinetic rates were similar for both tracers. But in the renal cortex, uptake of 11 C-Ac was higher compared to 11 C-AcAc, while the reverse was observed for the clearance. Interestingly, infusion of 11 C-AcAc led to a significantly delayed release of radioactivity in the renal medulla and pelvis, a phenomenon not observed with 11 C-Ac. This suggests an equilibrium of 11 C-AcAc with the other ketone, 11 C-D-beta-hydroxybutyrate, and a different clearance profile. Overall, this suggests that in the kidney, the absorption and metabolism of 11 C-AcAc is different compared to 11 C-Ac. This dual tracer PET protocol provides the opportunity to explore the relative importance of ketone metabolism in cardiac and renal diseases, and to improve our mechanistic understanding of new metabolic interventions targeting these two organs.
No takes yet. Share an insight, caveat, or question.
Cuenoud et al. (2023) conducted a cross-sectional in Healthy (n=10). 11C-acetoacetate vs. 11C-acetate was evaluated on Renal cortical uptake rate (K1) in mL/min/g (p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: